Mohamed Abdel Khabir

Mr. Mohamed Abdel Khabir is EFG Hermes’ Group Chief Financial Officer, and a board member in several EFG Hermes subsidiaries. Prior to his current post, Mr. AbdelKhabir joined EFG Hermes’ Investment Banking division in early 2008, where he remained until March 2016 as a Director.

Mr. AbdelKhabir’s notable transactions during his investment banking tenure include the IPO of Integrated Diagnostics Holding (IDH) through a secondary offering worth USD 334 million in the LSE. He was also involved in the sale of Cleopatra Hospital in Egypt to the Abraaj Group, the merger of Al Borg and Al Mokhtabar laboratories, ENPC’s USD 1.05 billion syndicated loan, and the issuance of ODH EDRs worth USD 1.8 billion.

Previously, he held the position of Financial Planning Manager at Procter and Gamble in the Corporate Finance division with a focus on financial planning, budgeting, corporate restructure, integration, and profit forecasting.

Mr. AbdelKhabir holds a BA in Business Administration from the American University in Cairo with a concentration in Finance and a minor in Economics and Psychology. He is also a CFA charter-holder.